bgb-3245
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 24, 2020 (NCT04249843)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06194877 | Phase 1 | Apr 18, 2024 | MapKure, LLC |
| NCT05580770 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2023 | SpringWorks Therapeutics, Inc. |
| NCT04249843 | Phase 1 | Jan 24, 2020 | BeOne Medicines, MapKure, LLC |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MapKure, LLC | For profit | 2 | 2 | 1 | 2020 |
| BeOne Medicines | For profit | 1 | 0 | 1 | 2020 |
| SpringWorks Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2023 |
3 organizations
Page 1 / 1